Arcus Biosciences - Funding, Financials, Valuation, Investors - Cointime

Bitcoin $59,027.72 -0.71%
Ethereum $1,590.11 +0.47%
BNB $550.36 -0.40%
Optimism $0.10 -2.57%
Arbitrum $0.08 +1.96%
Solana $75.45 +1.92%
Polygon $0.22 +2.77%
Cosmos $1.53 +0.67%
Avalanche $6.70 +1.25%

Bitcoin $59,027.72 -0.71%
Ethereum $1,590.11 +0.47%
BNB $550.36 -0.40%
Optimism $0.10 -2.57%
Arbitrum $0.08 +1.96%
Solana $75.45 +1.92%
Polygon $0.22 +2.77%
Cosmos $1.53 +0.67%
Avalanche $6.70 +1.25%

Arcus Biosciences

company

Investors

Number of Lead Investors

Number of Investors

3

18

Arcus Biosciences is funded by 18 investors. Gilead Sciences and GV are the most recent investors.

Investor Name	Lead Investor	Funding Round
Gilead Sciences	Yes	Post-IPO Equity
GV	Yes	Series C
Aisling Capital	-	Series C
Biotechnology Value Fund	-	Series C
Celgene	-	Series C
Decheng Capital	-	Series C
Droia Ventures	-	Series C
EcoR1 Capital	-	Series C
Foresite Capital	-	Series C
Hillhouse Capital Group	-	Series C
Invus	-	Series C
Leerink Partners	-	Series C
Taiho Ventures	-	Series C
The Column Group	-	Series C
Wellington Management	-	Series C
Novartis	-	Series B
RTA Capital	-	Series B
Stanford University	-	Series B